Last reviewed · How we verify

NCT07098325

Biological Reaction of Direct 3d Printed Retainers

Recruiting now NA Last updated 1 August 2025
What this trial tests

NA trial testing retainer with .5 mm thickness in Orthodontic Retainers in 26 participants. Currently enrolling.

Timeline
1 October 2025
Primary endpoint
1 April 2027
1 June 2027

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment26
Start date1 October 2025
Primary completion1 April 2027
Estimated completion1 June 2027
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Eligibility, any sex, with Orthodontic Retainers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study will be to evaluate the biological reaction of direct three dimensional printed retainers. Primary objective is to evaluate bacterial growth and color stability between different thicknesses of 3d printed material used as a retainer . Secondary objective is to determine the optimal thickness for use in clear aligner fabrication based on biological performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07098325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing